Maria Geijo

Dr. Maria Geijo

NEIKER- Basque Institute for Agricultural Research and Development
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Journal of Comparative Pathology
Verified
Journal Article
Closed access
JGJ. González
J. González
MGMaria Geijo
Maria Geijo
CGC. García-Pariente
C. García-Pariente
AVA. Verna
A. Verna
Juan Manuel CorpaJuan Manuel Corpa
Juan Manuel Corpa
VPValentin Perez
Valentin Perez

14 September 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JGJoseba M. Garrido
Joseba M. Garrido
ISIker A. Sevilla
Iker A. Sevilla
BBBeatriz Beltrán-Beck
Beatriz Beltrán-Beck
EMEsmeralda Minguijon
Esmeralda Minguijon
CBCristina Ballesteros
Cristina Ballesteros
CGChristian Gortázar
Christian Gortázar
Tuberculosis (TB) caused by Mycobacterium bovis and closely related members of the Mycobacterium tuberculosis complex continues to affect humans and animals worldwide and its control requires vaccination of wildlife reservoir species such as Eurasian wild boar (Sus scrofa). Vaccination efforts for TB control in wildlife have been based primarily on oral live BCG formulations. However, this is the first report of the use of oral inactivated vaccines for controlling TB in wildlife. In this study, four groups of 5 wild boar each were vaccinated with inactivated M. bovis by the oral and intramuscular routes, vaccinated with oral BCG or left unvaccinated as controls. All groups were later challenged with a field strain of M. bovis. The results of the IFN-gamma response, serum antibody levels, M. bovis culture, TB lesion scores, and the expression of C3 and MUT genes were compared between these four groups. The results suggested that vaccination with heat-inactivated M. bovis or BCG protect wild boar from TB. These results also encouraged testing combinations of BCG and inactivated M. bovis to vaccinate wild boar against TB. Vaccine formulations using heat-inactivated M. bovis for TB control in wildlife would have the advantage of being environmentally safe and more stable under field conditions when compared to live BCG vaccines. The antibody response and MUT expression levels can help differentiating between vaccinated and infected wild boar and as correlates of protective response in vaccinated animals. These results suggest that vaccine studies in free-living wild boar are now possible to reveal the full potential of protecting against TB using oral M. bovis inactivated and BCG vaccines.

1 December 2005 in Scientific and Technical Review
Verified
Journal Article
Closed access
ISIker A. Sevilla
Iker A. Sevilla
SSS.V. Singh
S.V. Singh
JGJ.M. Garrido
J.M. Garrido
GAG. Aduriz
G. Aduriz
SRS. Rodriguez
S. Rodriguez
RJR.A. Juste
R.A. Juste

1 March 2009 in International Journal of Infectious Diseases
Verified
Journal Article
Closed access
RJRamón A Juste
Ramón A Juste
NENatalia Elguezabal
Natalia Elguezabal
APAndrés Pavón
Andrés Pavón
JGJoseba M. Garrido
Joseba M. Garrido
MGMaria Geijo
Maria Geijo
AIAnder Izeta
Ander Izeta

2 July 2008 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RJRamón A Juste
Ramón A Juste
NENatalia Elguezabal
Natalia Elguezabal
JGJoseba M. Garrido
Joseba M. Garrido
APAndres Pavon
Andres Pavon
MGMaria Geijo
Maria Geijo
RGRobert J. Greenstein
Robert J. Greenstein
Mycobacteria, such as M. leprae and M. tuberculosis infect billions of humans. However, because of appropriate immune responses and antibiotic therapy, overt mycobacterial diseases occur far less frequently. M. avium subspecies paratuberculosis (MAP) causes Johne's disease in ruminants, an affliction evocative of inflammatory bowel disease (IBD). Several agents used to treat IBD (5-ASA, methotrexate, azathioprine and its metabolite 6-MP) have recently been shown to be antiMAP antibiotics. We herein evaluate the prevalence of MAP DNA in healthy individuals and compare them with IBD patients on antiMAP antibiotics. We studied 100 healthy individuals (90 blood donors) and 246 patients with IBD. IS900 MAP DNA was identified using a nested primer PCR in the buffy coat of blood. Positive signal was confirmed as MAP by DNA sequence analysis. PCR positive results frequencies were compared according to medications used. Significance was accepted at p<0.05. 47% (47/100) healthy controls and 16% (40/246) IBD patients were IS900 positive (p<0.0001). MAP DNA was identified in 17% of 143 patients receiving mesalamine and 6% of 16 receiving sulfasalazine. None of the IBD patients receiving methotrexate (n = 9), 6-MP (n = 3), ciprofloxacin (n = 5) or Tacrolimus® (n = 3) had MAP DNA detectable in their blood. We found a disquietingly large percentage of healthy individuals have MAP DNA in their blood, the significance of which remains to be determined. Counter-intuitively, the incidence of MAP DNA was significantly lower in patients with IBD. Agents with the most potent in vitro antiMAP activity were associated with clearance of blood MAP DNA. We posit that the use antiMAP antibiotics was responsible for the decreased prevalence of MAP DNA in patients with IBD.

1 May 2009 in Foodborne Pathogens and Disease
Verified
Journal Article
Closed access
MAMarta Alonso-Hearn
Marta Alonso-Hearn
EMElena Molina
Elena Molina
MGMaria Geijo
Maria Geijo
PVPatricia Vázquez
Patricia Vázquez
ISIker A. Sevilla
Iker A. Sevilla
RJRamón A Juste
Ramón A Juste
Johne's disease or paratuberculosis is a chronic granulomatous inflammation of the small intestine of ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP). Recent studies suggest an association between MAP and Crohn's disease in humans. MAP can become widely distributed within the tissues of infected animals, and meat may be a possible route of exposure of MAP to humans. In this study, 47 dairy and beef cattle were examined for the occurrence of viable MAP in diaphragm muscle. At the slaughterhouse, gut tissues, diaphragm muscle, blood, and feces of the 47 animals were collected for bacteriological culture, as well as gut samples for histopathological analysis. MAP was detected by bacteriological culture and conventional and real-time IS900 polymerase chain reaction in the diaphragm muscle of six infected cattle at slaughter (13%). The six animals showing evidence of MAP in diaphragm muscle had diffuse lesions and severe granulomatous inflammation in ileocecal lymph nodes, jejunal lymph nodes, ileocecal valve, and ileum. All six had heavy bacterial load in mesenteric lymph nodes, ileocecal valve, ileum, and jejunum, and four showed clinical signs of paratuberculosis. Two animals did not show clinical signs but had viable MAP in intestinal tissues and in diaphragm muscle as well. MAP was found in blood of only one of the six animals showing evidence of MAP in diaphragm muscle and in feces of three of them. In general, there was a positive association between enteric lesion severity, clinical signs of paratuberculosis, heavy bacterial load in intestinal tissues, fecal shedding of MAP, and the presence of disseminated MAP infection in diaphragm muscle. The results of this study demonstrated that MAP can be detected and cultured from muscle of MAP-infected cattle destined for human consumption and suggest a possible risk of exposure of humans to MAP via contaminated meat.